Determination of multi-drug resistant Klebsiella pneumoniae isolated from UTI patients in Wasit province, Iraq

Fatimah E. Alquraishi; Zainab N. AL-Saadi; Jalal A. T. Al-Azzawi

doi:10.53730/ijhs.v6nS6.12186

Authors

Fatimah E. Alquraishi
fatimaenad6@gmail.com
Department of Biology, College of Science, University of Wasit, Wasit, Iraq
Zainab N. AL-Saadi Department of Biology, College of Science, University of Wasit, Wasit, Iraq
Jalal A. T. Al-Azzawi Ministry of Health, Wasit Health Directorate, Wasit Governorate, Iraq

Keywords:

multi-drug resistant, Klebsiella pneumonia, UTI patient

Abstract

The noticeable increase in the occurrence of multidrug-resistant Klebsiella pneumoniae strains separated from different hospitals in Wasit Province-Iraq demonstrates the limitation of antibiotics used for bacterial eradication. The aim of the present study is to detect the virulence genes in some K. pneumoniae isolates that collected from different hospitals in Wasit Province-Iraq. A total of 525 clinical samples were used to isolate 77 K. pneumoniae strains from clinical specimens throw fife months. They were identified by microbiological method as K. pneumoniae. The antimicrobial susceptibility of K. pneumoniae isolates was determined. The existence of virulence genes (AcrAB and tolC) were performed by PCR. The multidrug-resistant isolates showed resistance against Gentamicin (3.89%), Tobramycin (15.58%), and Amikacin (12.98%), which belongs to aminoglycoside antibiotics. Morever, βeta-Lactam antibiotics include Penicillins: Ampicillin (100%), Augmentin (19.48%), Carbapenems class including: Polymyxin-B (2.59%), and Imipenem (19.48%), Tetracyclins represented by Tetracycline (27.27%), Quinolones class including Ciprofloxacin (19.48%), Levofloxacin (14.28%), and Norfloxacin (14.28%), Macrolidies class including Azithromycin (57.14%),Amphenicols class including Chloramphenicol (1.29%),Nitrofurans class including Nitrofurantion (57.14%), finally Co-Trimoxazole class including Trimethoprim (33.76%). Molecular diversity between K. pneumoniae isolates was determined using Multiplex PCR technique.

Downloads

Download data is not yet available.

References

Abdelraheem, W., Abdelkader, A. E., & Mohamed, E. S. (2020). Detection of biofilm formation and assessment of biofilm genes expression in different Pseudomonas aeruginosa clinical isolates. Meta Gene, 100646.

Al-Hasnawi, H. (2020).Detection of Carbapenem Resistant Genes and Class I Integron among Clinical Isolates of Klebsiellapneumoniae from Main Hospitals in Al-Najaf.Ph.D. Dissertation. University of Kufa.

Al-JemelyH. T.N.(2017). A comparative study of the bacterial virulence factors isolated from urinary tract infections for cardiac care unit patients.M.Sc. Thesis. Diyala University.

Al-Musawi, A.M. (2018). Genotypic and phenotypic typing of clinical Klebsiellapneumoniaelocal isolates. M.Sc. Thesis. Mustansiriyah University.

Al-Rubyaie, N.S. (2021). Detection of antiseptic resistant genes in multidrug resistant Pseudomonas aeruginosaand Klebsiellapneumoniaefrom hospital environment. M.Sc. Thesis. Mustansiriyah University, Iraq.

Alsamarai A. M. and Ali S. (2016). Urinary tract infection in female in Kirkuk, Iraq: risk factors. World Journal of Pharmacy and Pharmaceutical Sciences, 5 (6): 180-195.

Bachay Z.A.(2018).Molecular Comparison of Adhesins and Phylogroups of UropathogenicEscherichia coli Isolates From Patients with First Time and Recurrent Urinary Tract Infection. . M.Sc. Thesis. Wasit University.

Bleriot, I., Blasco, L., Delgado-Valverde, M., Gual de Torella, A., Ambroa, A., Fernandez-Garcia, L., Lopez, M., Oteo, J., Wood, T., Pascual, A., Bou, G., Fernandez-Cuenca, F., & Tomas, M. (2020). Mechanisms of Tolerance and Resistance to Chlorhexidine in Clinical Strains of KlebsiellapneumoniaeProducers of Carbapenemase: Role of New Type II Toxin-Antitoxin System, PemIK. Toxins, 12(9), 566.

Bleriot, I., Blasco, L., Delgado-Valverde, M., Gual de Torella, A., Ambroa, A., Fernandez-Garcia, L., Lopez, M., Oteo, J., Wood, T., Pascual, A., Bou, G., Fernandez-Cuenca, F., & Tomas, M. (2020). Mechanisms of Tolerance and Resistance to Chlorhexidine in Clinical Strains of KlebsiellapneumoniaeProducers of Carbapenemase: Role of New Type II Toxin-Antitoxin System, PemIK. Toxins, 12(9),566.

Brooks, G.F.; Karen, C. and Carroll, M. D. (2007). Medical Microbiology. Jawetz, Melnick and adelberg’s. 24th .ed. McGraw-Hill Companies, Inc. USA. p:266-67.

Cepas, V., López, Y., Muñoz, E., Rolo, D., Ardanuy, C., Martí, S., Xercavins, M., Horcajada, J.P, Bosch, J. & Soto, S. M. (2019). Relationship between biofilm formation and antimicrobial resistance in gram-negative bacteria. Microbial Drug Resistance, 25(1), 72-79.

CLSI. (2021). Performance standards for antimicrobial susceptibility testing. 31th ed. CLSI supplement. M100.

Collee, J.; Fraser, A.; Marmion, B. and Simons A. (1996). Mackie and McCartney’s Practical Medical Microbiology. (14thed.). Churchill livingstone, U.S.A., P:561.

Effah, C. Y., Sun, T., Liu, S., & Wu, Y. (2020).Klebsiellapneumoniae: an increasing threat to public health. Annals of Clinical Microbiology and Antimicrobials, 19(1), 1-9.

Essa, R. H.; Al-Zubaidi, H. K. A.; Rasool, K. H.; Hussein, N. H. (2016).Study of some bacteriological and immunological parameters in urinary tractinfection of pregnant women. International Education & Research Journal. 2: 2454-9916.

Fatima, S., Liaqat, F., Akbar, A., Sahfee, M., Samad, A., Anwar, M., & Khan, A. (2021). Virulent and multidrug‐resistant Klebsiellapneumoniaefrom clinical samples in Balochistan. International Wound Journal.

Ferreira, R., Silva, B., Rezende1, G., Silva, R., Silva, A., Campanini1, E., Brito, M., Silva, E., Freire, C., Cunha, A., and Pranchevicius, M. (2019).High Prevalence of Multidrug-Resistant Klebsiellapneumoniae Harboring Several Virulence and b-Lactamase Encoding Genes in a Brazilian Intensive Care Unitdoi: 10.3389/fmicb.2018.03198.

Forbes, B. ; Sahm, D, and Weissfeld, A. (2014).Enterobacteriaceae. In: Wilson L, Wurm E, Bailey and Scott's Diagnostic Microbiology. 13th .ed. St. Louis, Mosby Elsevier. p. 323-33.

Forbes, B. A.; Sahm, D. F.; Weissfeld, A. S. (2002). Bailey and Scott’s Diagnostic Microbiology, Mosby, St. Louis, Mo, USA, 11th edition.

Hussein, N. H. (2018). Emergence of NDM-1 among carbapenem-resistant Klebsiellapneumoniaein Iraqi hospitals. Actamicrobiologica et immunologicaHungarica, 65(2), 211-227.

Iranpour, D.; Hassanpour, M; Ansari, H.; Tajbakhsh, S.; Khamisipour, G.; and Najafi A. (2015). Phylogenetic groups of Escherichia coli strains from patients with urinary tract infection in iran based on the new Clermont phylotyping method. BioMed Research International. 2015: 1-7.

Kareem, S. M., Al-kadmy, I. M., Kazaal, S. S., Ali, A. N. M., Aziz, S. N., Makharita, R. R, Algammal, A.M., Al-Rejaie, S., Behl, T., Batiha, G.E.S., El-Mokhtar, M.A., &Hetta, H. F. (2021). Detection of gyrAand parCMutations and Prevalence of Plasmid-Mediated Quinolone Resistance Genes in Klebsiellapneumoniae. Infection and Drug Resistance, 14, 555-563.

Liu, C., &Guo, J. (2019).HypervirulentKlebsiellapneumoniae(hyperm- ucoviscous and aerobactin positive) infection over 6 years in the elderly in China: antimicrobial resistance patterns, molecular epidemiology and risk factor. Annals of clinical microbiology and antimicrobials, 18(1), 1-11.

MacFaddin, J. F. (2000). Biochemical Tests for Identification of Medical Bacteria (3rd ed.). Lippincott Williams and Wilkins, London.

Martin, R.M & Bachman, M.A (2018) Colonization, Infection, and the Accessory Genome of Klebsiellapneumoniae. Frontiers in cellular and infection microbiology, (8)4, 1-15.

Martínez, J. L., &Baquero, F. (2002). Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance. Clinical microbiology reviews, 15(4), 647-679.

Mirzaie, A. and Ranjbar, R (2021).Antibiotic resistance, virulence associated genes analysis and molecular typing of Klebsiellapneumoniaestrains recovered from clinical samples.doi.org/10.1186/s13568-021-01282-w.

Nirwati, H., Sinanjung, K., Fahrunissa, F., Wijaya, F., Napitupulu, S., Hati, V. P. &Nuryastuti, T. (2019). Biofilm formation and antibiotic resistance of Klebsiellapneumoniae isolated from clinical samples in a tertiary care hospital, Klaten, Indonesia. In BMC proceedings (Vol. 13, No. 11, pp. 1-8). BioMed Central.

Parmin, P., Suarayasa, K., & Wandira, B. A. (2020). Relationship between quality of service with patient loyality at general polyclinic of kamonji public health center. International Journal of Health & Medical Sciences, 3(1), 86-91. https://doi.org/10.31295/ijhms.v3n1.157

Suay-García, B., & Pérez-Gracia, M. T. (2019). Present and future of carbapenem-resistant Enterobacteriaceae (CRE) infections. Antibiotics, 8(3), 122.

Surgers, L. ; Boyd, A. ; Girard, P.M. ; Arlet, G. and Decré, D. (2016). ESBL-Producing Strain of HypervirulentKlebsiellapneumoniaeK2, France. Emerg. Infect. Dis. 22(9): 1687–688.

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). The COVID-19 pandemic. International Journal of Health Sciences, 5(2), vi-ix. https://doi.org/10.53730/ijhs.v5n2.2937

Ugakli, S., &Dogan, M. (2020). Growing Threat Increased Carbapenem-resistance Among KlebsiellaPneumoniae; Antibiotic Susceptibility Pattern of Klebsiellapneumoniaein A Tertiary Care Hospital. International Journal of Clinical Microbiology, 1(2), 1.

Vandepitte, J.; Verhaegen, J.; Enbaek, K.; Rohner, P.; Piot, P. and Heuck, C.C. (2003). Basic Laboratory Procedures in Clinical Bacteriology . 2nd ed . WHO., Geneva.

Venkatachalam, I.; Teo, J.; Balm, M.; Fisher, D.; Jureen, R. and Lin, R. (2014).Klebsiella pneumonia carbapenemase-producing enterobacteria in hospital, Singapore. Emerging Infection Dis., 18:1381-1383.

Verma, P.; Berwal, P.K.; Nagaraj, N.; Swami,S.; Jivaji, P. and Narayan, S. (2015). Neonatal sepsis: epidemiology, clinical spectrum, recent antimicrobial agents and their antibiotic susceptibility pattern. Intern. J. Contemporary Pediatrics, 2:176-180.

Walsh, T. R. (2010). Emerging carbapenemases: a global perspective. International journal of antimicrobial agents, 36, S8-S14.